1 Min Read
Aug 11 (Reuters) - Cadila Healthcare Ltd:
* Says Zydus receives tentative approval from USFDA for mesalamine suppositories for rectal use Source text: (bit.ly/2vtrVOm) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.